Relapsed, Refractory
Showing 9951 - 9975 of >10,000
Brain and CNS Tumors, Metastatic Cancer Trial in Milwaukee (verteporfin, conventional surgery)
Unknown status
- Brain and Central Nervous System Tumors
- Metastatic Cancer
- verteporfin
- conventional surgery
-
Milwaukee, Wisconsin
- +1 more
Sep 19, 2013
Lymphoma Trial in Chicago, New York (arsenic trioxide)
Terminated
- Lymphoma
- arsenic trioxide
-
Chicago, Illinois
- +1 more
Jun 7, 2012
Lymphoma, Non-Hodgkin Trial in Worldwide (Taxane (Cytotoxic, BAY59-8862))
Completed
- Lymphoma, Non-Hodgkin
- Taxane (Cytotoxic, BAY59-8862)
-
Miami Beach, Florida
- +22 more
Oct 10, 2013
Prostate Cancer Trial in New Brunswick (2-deoxyglucose)
Terminated
- Prostate Cancer
-
New Brunswick, New JerseyThe Cancer Institute of New Jersey
Nov 15, 2013
Lymphoma Trial in Worldwide (biological, drug, procedure)
Unknown status
- Lymphoma
- filgrastim
- +11 more
-
Antwerp, Belgium
- +43 more
Sep 16, 2013
Systemic Lupus Erythematosus Trial in Nanjing (human umbilical cord derived MSC transplantation for SLE)
Unknown status
- Systemic Lupus Erythematosus
- human umbilical cord derived MSC transplantation for SLE
-
Nanjing, Jiangsu, ChinaThe Affiliated Drum Tower Hospital of Nanjing University Medical
Nov 1, 2013
Hepatopulmonary Syndrome Trial in New Delhi (pentoxifylline and rifaximin, Pentoxifylline and )
Unknown status
- Hepatopulmonary Syndrome
- pentoxifylline and rifaximin
- Pentoxifylline and placebo
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Dec 16, 2013
Hodgkin's Lymphoma Trial in Houston (Obatoclax mesylate (GX15-070MS))
Completed
- Hodgkin's Lymphoma
- Obatoclax mesylate (GX15-070MS)
-
Houston, TexasMD Anderson Cancer Center
Aug 3, 2012
Multiple Myeloma and Plasma Cell Tumor Trial in Hackensack, New Hyde Park, Philadelphia (fluphenazine HCl)
Completed
- Multiple Myeloma and Plasma Cell Neoplasm
- fluphenazine hydrochloride
-
Hackensack, New Jersey
- +2 more
Nov 5, 2013
Clostridium Difficile, Clostridium Difficile Infection Trial in Tuebingen (FMT, Vancomycin)
Unknown status
- Clostridium Difficile
- Clostridium Difficile Infection
- FMT
- Vancomycin
-
Tuebingen, GermanyUniversitaetsklinikum Tuebingen
Oct 10, 2013
Lymphoma, Follicular Trial in Puerto Rico, United States (Sargramostim (Leukine), Rituximab)
Terminated
- Lymphoma, Follicular
- Sargramostim (Leukine)
- Rituximab
-
Birmingham, Alabama
- +21 more
Dec 2, 2013
MDS Trial in Amarillo (Clofarabine)
Terminated
- Myelodysplastic Syndromes
-
Amarillo, TexasTexas Oncology Cancer Center
Mar 12, 2013
Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in New York (beta-glucan, rituximab)
Terminated
- Leukemia
- +2 more
- beta-glucan
- rituximab
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Mar 18, 2013
Chronic GVHD Trial in Madrid (Allogenic Mesenchymal Stem Cell)
Completed
- Chronic Graft-Versus-Host Disease
- Allogenic Mesenchymal Stem Cell
-
Madrid, SpainGrupo Espanol de trasplantes hematopoyeticos y terapia celular
Sep 30, 2013
Leukemia, MDS Trial in Columbus, Houston (7-hydroxystaurosporine (UCN-01), Cytarabine (Ara-C))
Completed
- Leukemia
- Myelodysplastic Syndromes
- 7-hydroxystaurosporine (UCN-01)
- Cytarabine (Ara-C)
-
Columbus, Ohio
- +1 more
Jul 27, 2012
Refractory Cancer Trial in Seoul
Unknown status
- Refractory Cancer
-
Seoul, Gyunggido, Korea, Republic ofSamsung Medical Center
Aug 27, 2013
Gastroesophageal Reflux, Nervous System Diseases, Fundoplication Trial in Salt Lake City (Fundoplication, Gastrojejunal (GJ)
Completed
- Gastroesophageal Reflux
- +3 more
- Fundoplication
- Gastrojejunal (GJ) feeding tube
-
Salt Lake City, UtahPrimary Children's Medical Center
Oct 17, 2013
Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine, rituximab, sargramostim)
Terminated
- Lymphoma
- autologous immunoglobulin idiotype-KLH conjugate vaccine
- +2 more
-
Birmingham, Alabama
- +59 more
Aug 1, 2013
Cardiac Transplantation, Skin Cancer Trial in Lyon (Everolimus)
Unknown status
- Cardiac Transplantation
- Skin Cancer
-
Lyon, FranceHOSPICES CIVILS de LYON
Dec 11, 2013
Lymphoma Trial in Omaha (rituximab, yttrium Y 90 ibritumomab tiuxetan)
Completed
- Lymphoma
- rituximab
- yttrium Y 90 ibritumomab tiuxetan
-
Omaha, NebraskaUNMC Eppley Cancer Center at the University of Nebraska Medical
Dec 13, 2013
Leukemia Trial in Buenos Aires (asparaginase, cytarabine, daunorubicin HCl)
Unknown status
- Leukemia
- asparaginase
- +7 more
-
Buenos Aires, ArgentinaGrupo Argentino de Tratamiento de la Leucemia Aguda
Sep 19, 2013